Skip to main content

Table 1 Clinical pathological characteristics of TP-MBC compared with TP-FBC

From: Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits

 

TP-MBC (n = 336)

TP-FBC (n = 33,339)

P-value

Age

< 0.001

  ≤ 50

46 (13.7)

10,928 (32.8)

 

 50< ≤65

132 (39.3)

12,628 (37.9)

 

  > 65

158 (47.0)

9783 (29.3)

 

Race

< 0.001

 White

266 (79.2)

25,738 (77.2)

 

 Black

51 (15.2)

3588 (10.8)

 

 A/PI

18 (5.3)

3525 (10.5)

 

 Other

1 (0.3)

488 (1.5)

 

Histology

< 0.001

 Ductal

308 (91.7)

28,165 (84.4)

 

 Lobular and Mix

13 (3.8)

4053 (12.2)

 

 Other

15 (4.5)

1121 (3.4)

 

Grade

0.122

 I-II

149 (44.3)

16,565 (49.7)

 

 III-IV

171 (50.9)

15,112 (45.3)

 

 Unknown

16 (4.8)

1662 (5.0)

 

Stage

< 0.001

 I

79 (23.5)

13,068 (39.2)

 

 II

147 (43.7)

12,606 (37.8)

 

 III

60 (17.9)

4477 (13.5)

 

 IV

37 (11.0)

2313 (6.9)

 

 Unknown

13 (3.9)

875 (2.6)

 

T

< 0.001

 T0–1

106 (31.5)

16,075 (48.2)

 

 T2

160 (47.6)

11,926 (35.8)

 

 T3

11 (3.3)

2344 (7.0)

 

 T4

46 (13.7)

1894 (5.7)

 

 Unknown

13 (3.9)

1100 (3.3)

 

N

< 0.001

 N0

160 (47.6)

19,891 (59.7)

 

 N1

118 (35.1)

9436 (28.3)

 

 N2

29 (8.6)

2120 (6.4)

 

 N3

20 (6.0)

1289 (3.8)

 

 unknown

9 (2.7)

603 (1.8)

 

M

0.006

 M0

297 (88.4)

30,942 (92.8)

 

 M1

37 (11.0)

2311 (6.9)

 

 Unknown

2 (0.6)

86 (0.3)

 

Surgery

0.083

 Yes

285 (84.8)

29,494 (88.5)

 

 No

45 (13.4)

3254 (9.8)

 

 Unknown

6 (1.8)

591 (1.8)

Â